Parkinson's disease affects more than 1.1 million people in the United States, progressively damaging the brain cells that control movement. By the time symptoms like tremors appear, patients have already lost around half ...
Nov 25, 2025
0
0
A new evidence brief, based on a study by the Juno Evidence Alliance conducted in collaboration with CABI's One Health Hub, has highlighted that a One Health approach is needed in research into zoonotic disease risks around ...
Nov 26, 2025
0
0
Getting treatment within one week of a serious head injury can reduce the risk of developing Alzheimer's disease by up to 41%, according to new research from Case Western Reserve University.
Nov 25, 2025
0
0
Myelodysplastic syndrome (MDS) is independently associated with incident cardiovascular disease (CVD), according to a study published online Nov. 10 in the Canadian Journal of Cardiology.
Nov 25, 2025
0
0
A new study led by Peter Mac Professor Louise Cheng on fruit-fly brains has uncovered how cells that form the brain's protective barrier can act as "gatekeepers" and slow down the growth of some brain tumors.
Nov 24, 2025
0
0
Biomedical research that began at the University of Virginia School of Medicine has yielded a much-needed new treatment for patients with the deadliest form of blood cancer.
Nov 25, 2025
0
1
A new paper from the University of Kansas overturns the idea that a "risk gene" carried by millions of people worldwide influences production of type 1 interferon, a workhorse of the immune system. The work is published in ...
Nov 25, 2025
0
0
U.S. Food and Drug Administration (FDA) advisory committees play a key role in evaluating the efficacy and safety of new drugs. They include open public hearing sessions, whereby patients, clinicians, and advocates share ...
Nov 24, 2025
0
0
With the federal government reopened after a weeks-long shutdown that disrupted food assistance across the country, a new University of Massachusetts Amherst Labor Center working paper shows that more than 1 in 10 workers ...
Nov 25, 2025
0
0
A randomized trial led by Lilia Cervantes, MD, MSc, professor of hospital medicine at the University of Colorado Anschutz School of Medicine, has found that a culturally tailored intervention helped achieve a modest reduction ...
Nov 24, 2025
0
0
